Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
aTyr Pharma, Inc. - Common Stock
(NQ:
ATYR
)
2.240
+0.010 (+0.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,687,376
Open
2.240
Bid (Size)
2.350 (1)
Ask (Size)
2.390 (5)
Prev. Close
2.230
Today's Range
2.180 - 2.300
52wk Range
1.420 - 2.500
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
aTyr Pharma’s Lead Therapeutic Candidate Efzofitimod for Pulmonary Sarcoidosis to be Featured in Best of CHEST Journals at CHEST 2024 Annual Meeting
October 08, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 04, 2024
Via
Benzinga
Performance
YTD
+23.08%
+23.08%
1 Month
+17.28%
+17.28%
3 Month
+26.91%
+26.91%
6 Month
+23.08%
+23.08%
1 Year
+23.08%
+23.08%
More News
Read More
aTyr Pharma Announces Publication Demonstrating Efficacy of Efzofitimod in Pulmonary Sarcoidosis in the European Respiratory Journal
October 02, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma to Participate in September Investor Conferences
August 21, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
ATYR Stock Earnings: aTyr Pharma Beats EPS for Q2 2024
August 13, 2024
Via
InvestorPlace
aTyr Pharma Announces Second Quarter 2024 Results and Provides Corporate Update
August 13, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
August 06, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
aTyr Pharma Announces Research Study with Stanford Medicine
July 30, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
Super League Enterprise And 2 Other Stocks Under $2 Insiders Are Buying
July 25, 2024
Via
Benzinga
aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
July 22, 2024
From
aTyr Pharma, Inc.
Via
GlobeNewswire
ATYR Stock Earnings: aTyr Pharma Beats EPS for Q2 2023
June 10, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.